213 related articles for article (PubMed ID: 30796009)
21. Is There Any Clinical Value of Adding 123I-Metaiodobenzylguanidine Myocardial Scintigraphy to 123I-Ioflupane (DaTscan) in the Differential Diagnosis of Parkinsonism?
Stathaki M; Koukouraki S; Simos P; Boura I; Papadaki E; Bourogianni O; Tsaroucha A; Kapsoritakis N; Mitsias P; Spanaki C
Clin Nucl Med; 2020 Aug; 45(8):588-593. PubMed ID: 32404715
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Dopamine Transporter SPECT and 123I-MIBG Myocardial Scintigraphy to Assess Clinical Severity in Patients With Parkinson Disease.
Okano N; Niitsu M; Tanaka J; Sasaki T; Takahashi K; Araki N; Yamamoto T; Nakano S; Nishimura S; Senbonmatsu T; Matsunari I
Clin Nucl Med; 2017 Jan; 42(1):7-14. PubMed ID: 27775946
[TBL] [Abstract][Full Text] [Related]
23. Obstructive Sleep Apnea and Striatal Dopamine Availability in Parkinson's Disease.
Oh YS; Kim JS; Lyoo CH; Kim H
Mov Disord; 2023 Jun; 38(6):1068-1076. PubMed ID: 37046390
[TBL] [Abstract][Full Text] [Related]
24. Comparison of I-123 MIBG planar imaging and SPECT for the detection of decreased heart uptake in Parkinson disease.
Oh JK; Choi EK; Song IU; Kim JS; Chung YA
J Neural Transm (Vienna); 2015 Oct; 122(10):1421-7. PubMed ID: 26003179
[TBL] [Abstract][Full Text] [Related]
25. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.
Orimo S; Ozawa E; Nakade S; Sugimoto T; Mizusawa H
J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):189-94. PubMed ID: 10406987
[TBL] [Abstract][Full Text] [Related]
26. Combined use of ¹²³I-metaiodobenzylguanidine (MIBG) scintigraphy and dopamine transporter (DAT) positron emission tomography (PET) predicts prognosis in drug-induced Parkinsonism (DIP): a 2-year follow-up study.
Kim JS; Oh YS; Kim YI; Yang DW; Chung YA; You IeR; Lee KS
Arch Gerontol Geriatr; 2013; 56(1):124-8. PubMed ID: 22633343
[TBL] [Abstract][Full Text] [Related]
27. Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson Disease-Related Cognitive Impairment.
Oh Y; Kim JS; Lyoo CH; Park G; Kim H
Neurology; 2024 Jul; 103(2):e209498. PubMed ID: 38885485
[TBL] [Abstract][Full Text] [Related]
28. Normal 'heart' in Parkinson's disease: is this a distinct clinical phenotype?
Kim JS; Park HE; Park IS; Oh YS; Ryu DW; Song IU; Jung YA; Yoo IR; Choi HS; Lee PH; Lee KS
Eur J Neurol; 2017 Feb; 24(2):349-356. PubMed ID: 27888574
[TBL] [Abstract][Full Text] [Related]
29. Low thalamic monoamine transporter availability is related to excessive daytime sleepiness in early Parkinson's disease.
Yoo SW; Oh YS; Ryu DW; Lee KS; Lyoo CH; Kim JS
Neurol Sci; 2020 May; 41(5):1081-1087. PubMed ID: 31872354
[TBL] [Abstract][Full Text] [Related]
30. Decreased thalamic monoamine availability in drug-induced parkinsonism.
Oh YS; Yoo SW; Lyoo CH; Kim JS
Sci Rep; 2022 Mar; 12(1):3749. PubMed ID: 35260679
[TBL] [Abstract][Full Text] [Related]
31. Premorbid cancer and motor reserve in patients with Parkinson's disease.
Oh YS; Yoo SW; Lyoo CH; Lee KS; Kim JS
Sci Rep; 2022 Jun; 12(1):9254. PubMed ID: 35660777
[TBL] [Abstract][Full Text] [Related]
32. 123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis.
Orimo S; Suzuki M; Inaba A; Mizusawa H
Parkinsonism Relat Disord; 2012 Jun; 18(5):494-500. PubMed ID: 22321865
[TBL] [Abstract][Full Text] [Related]
33. Early diagnosis of Lewy body disease in patients with late-onset psychiatric disorders using clinical history of rapid eye movement sleep behavior disorder and [
Fujishiro H; Okuda M; Iwamoto K; Miyata S; Torii Y; Iritani S; Ozaki N
Psychiatry Clin Neurosci; 2018 Jun; 72(6):423-434. PubMed ID: 29536584
[TBL] [Abstract][Full Text] [Related]
34. MIBG myocardial scintigraphy in pre-motor Parkinson's disease: a review.
Sakakibara R; Tateno F; Kishi M; Tsuyusaki Y; Terada H; Inaoka T
Parkinsonism Relat Disord; 2014 Mar; 20(3):267-73. PubMed ID: 24332912
[TBL] [Abstract][Full Text] [Related]
35. PR Prolongation and Cardiac 123I-MIBG Uptake Reduction in Parkinson's Disease.
Mochizuki H; Ebihara Y; Ugawa Y; Ishii N; Taniguchi A; Nagamachi S; Shiomi K; Nakazato M
Eur Neurol; 2015; 74(1-2):107-11. PubMed ID: 26303385
[TBL] [Abstract][Full Text] [Related]
36. Initial Versus Follow-up Sequential Myocardial 123I-MIBG Scintigraphy to Discriminate Parkinson Disease From Atypical Parkinsonian Syndromes.
Ryu DW; Kim JS; Lee JE; Oh YS; Yoo SW; Yoo IR; Lee KS
Clin Nucl Med; 2019 Apr; 44(4):282-288. PubMed ID: 30589669
[TBL] [Abstract][Full Text] [Related]
37. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.
Park SB; Kwon KY; Lee JY; Im K; Sunwoo JS; Lee KB; Roh H; Ahn MY; Park S; Kim SJ; Oh JS; Kim JS
Neurol Sci; 2019 Feb; 40(2):311-317. PubMed ID: 30415448
[TBL] [Abstract][Full Text] [Related]
38. Sequential imaging analysis using MIBG scintigraphy revealed progressive degeneration of cardiac sympathetic nerve in Parkinson's disease.
Watanabe M; Takeda T; Nakamagoe K; Tamaoka A
Eur J Neurol; 2011 Jul; 18(7):1010-3. PubMed ID: 21658161
[TBL] [Abstract][Full Text] [Related]
39. Potential multisystem degeneration in Asidan patients.
Ohta Y; Yamashita T; Hishikawa N; Sato K; Matsuzono K; Tsunoda K; Hatanaka N; Takemoto M; Takemi T; Takamatsu K; Abe K
J Neurol Sci; 2017 Feb; 373():216-222. PubMed ID: 28131191
[TBL] [Abstract][Full Text] [Related]
40. Sensitivity and specificity of cardiac metaiodobenzylguanidine scintigraphy in the early diagnosis of Parkinson's disease.
Brandl SJ; Braune S
Clin Auton Res; 2019 Dec; 29(6):567-574. PubMed ID: 29869732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
